We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+18.9%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.8B
AUM Growth
+$824M
Cap. Flow
+$356M
Cap. Flow %
9.35%
Top 10 Hldgs %
43.5%
Holding
460
New
148
Increased
43
Reduced
126
Closed
97

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$342M
2
MRUS
Merus
MRUS
+$152M
3
COOP
Mr. Cooper
COOP
+$123M
4
AVDX
AvidXchange
AVDX
+$85.1M
5
ETNB
89bio
ETNB
+$82.9M

Sector Composition

Rank Sector Weight
1 Financials 33.45%
2 Technology 18.96%
3 Healthcare 16.01%
4 Industrials 6.99%
5 Communication Services 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPKL
226
Spark I Acquisition Corp
SPKL
$101M
$687K 0.02%
60,100
-5,000
-8% -$56.9K
TACH
227
Titan Acquisition Corp
TACH
$360M
$678K 0.02%
66,118
VNMEU
228
Vendome Acquisition Corp I Unit
VNMEU
-63,042
Closed -$640K
TBMC
229
DELISTED
Trailblazer Merger Corp I
TBMC
$631K 0.02%
47,389
-211
-0.4% -$2.51K
CHAR
230
Charlton Aria Acquisition Corp
CHAR
$526K 0.01%
50,242
+2,528
+5% +$26.3K
CRANU
231
Crane Harbor Acquisition Corp II Units
CRANU
$503K 0.01%
+49,931
New +$502K
ODD icon
232
ODDITY Tech
ODD
$654M
$494K 0.01%
+12,300
New +$556K
EVAC.U
233
EQV Ventures Acquisition Corp II Units
EVAC.U
$492K 0.01%
48,629
GIWWR
234
GigCapital8 Rights
GIWWR
$464K 0.01%
+1,496,746
New +$556K
BIXIU
235
Bitcoin Infrastructure Acquisition Corp Unit
BIXIU
$455K 0.01%
+45,680
New +$457K
VACI.U
236
Viking Acquisition Corp I Units
VACI.U
$433K 0.01%
+43,239
New +$436K
AKAM icon
237
Akamai
AKAM
$16.7B
$428K 0.01%
+4,900
New +$403K
RNGT
238
Range Capital Acquisition Corp II
RNGT
$393K 0.01%
+39,484
New +$394K
AVDL
239
DELISTED
Avadel Pharmaceuticals
AVDL
$388K 0.01%
+18,000
New +$349K
APXTU
240
Apex Treasury Corp Units
APXTU
$328K 0.01%
+32,753
New +$330K
GSRFR
241
GSR IV Acquisition Corp Rights
GSRFR
$290K 0.01%
+125,000
New +$308K
TONT
242
Graf Global Corp
TONT
$153M
$272K 0.01%
25,326
CCIX
243
DELISTED
Churchill Capital Corp IX
CCIX
$266K 0.01%
25,000
DMIIR
244
Drugs Made In America Acquisition II Corp Right
DMIIR
$266K 0.01%
+1,899,899
New +$271K
MCGAU
245
Yorkville Acquisition Corp Unit
MCGAU
$158M
-5,000
Closed -$52.8K
EVAC.WS
246
EQV Ventures Acquisition Corp II Warrants
EVAC.WS
$244K 0.01%
696,009
-45,164
-6% -$16.1K
SBXD
247
SilverBox Corp IV
SBXD
$277M
$220K 0.01%
20,780
+780
+4% +$8.22K
WBD icon
248
PUT
Warner Bros
WBD
$65.9B
$201K 0.01%
+5,700
New +$133K
KRSP.U
249
Rice Acquisition Corp 3 Units
KRSP.U
$200K 0.01%
+19,045
New +$203K
EVOXU
250
Evolution Global Acquisition Corp Units
EVOXU
$179M
$178K ﹤0.01%
+17,711
New +$179K

Similar funds

Glazer Capital LLC's Q4 2025 Portfolio in Review

As of Q4 2025, Glazer Capital LLC held 460 positions worth $3.8B, up 28% from $2.98B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Glazer Capital LLC deployed $356M of net new capital in Q4 2025, opening 148 new positions and adding to 43 existing holdings. Its largest new stake was Avidity Biosciences: 2,467,139 shares worth $178M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was ProAssurance, an estimated $19M trimmed.

  • Glazer Capital LLC's largest Q4 2025 buy was Avidity Biosciences: 2,467,139 shares worth $178M.
  • Glazer Capital LLC added most to Dayforce in Q4 2025, an estimated $273M increase.
  • Glazer Capital LLC's biggest Q4 2025 reduction was ProAssurance, cutting an estimated $19M.
  • Glazer Capital LLC fully exited Verona Pharma in Q4 2025, selling an estimated $342M.
  • Glazer Capital LLC's ten largest holdings make up 44% of its $3.8B portfolio in Q4 2025.
  • Glazer Capital LLC opened 148 new positions and closed 97 in Q4 2025.
  • Glazer Capital LLC's portfolio value rose 28% quarter-over-quarter to $3.8B.

Based on Glazer Capital LLC's 13F filing for Q4 2025, filed 13 Feb 2026.